Breaking News Financial

Malt Lymphoma Pipeline | Companies – MEI Pharma, Incyte, Genentech, BeiGene, Sound Biologics, ADC Therapeutics, Loxo Oncology, and Others

DelveInsight, a leading market research and consulting firm, has recently published an in-depth report on the Malt Lymphoma pipeline, providing valuable insights into emerging therapies and companies. DelveInsight’s, “Mucosa-associated

Complicated Urinary Tract Infections (UTI) Pipeline Assessment Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Allecra, Iterum Therapeutics, Venatorx Pharma, Wockhardt

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 12+ key pharma and biotech companies are working on 12+ pipeline drugs in the Complicated Urinary Tract Infections therapeutics landscape

Constipation Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Anji Pharma, Yuhan, Theravance, RaQualia, Bayer, Abbott, AbbVie, Albireo

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 15+ key pharma and biotech companies are working on 15+ pipeline drugs in the Constipation therapeutics landscape based on different

Corneal Ulcer Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Trefoil, AmebaGone, Dobecure, OcuNexus, Recordati, Santen, Regeneratetx, Editas

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 15+ key pharma and biotech companies are working on 15+ pipeline drugs in the Corneal Ulcer therapeutics landscape based on

Coronary Artery Disease Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Idorsia, Novartis, Sinotau, XyloCor, AdvanceCor, AstraZeneca

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 30+ key pharma and biotech companies are working on 30+ pipeline drugs in the Coronary Artery Disease therapeutics landscape based

Prominent Investor Natalio Pabon Emphasizes the Significance of Identifying Potential Buyers in Business Sales

Atlanta, GA – Natalio Pabon, a distinguished investor renowned for his expertise in strategic business transactions, highlights the critical importance of identifying potential buyers when contemplating the sale of a

Critical Limb Ischemia Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Abbott, AnGes, BioGenCell, Ixaka, Caladrius, Helixmith, Hemostemix

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 10+ key pharma and biotech companies are working on 15+ pipeline drugs in the Critical Limb Ischemia therapeutics landscape based

Siyata Mobile Inc. (NASDAQ:SYTA) returns to growth with first quarter revenue more than doubling compared to the first quarter last year on strengthening sales

SYTA announced its financial results for the three months ended March 31, 2023. Revenues were $1.8 million compared to $0.8 million for the three months ended March 31, 2022. This

Roundtree Highlights What Sets Them Apart from Other Roofing Companies

Roundtree is a top-rated roofing company. In a recent update, the company explained the attributes that set them apart from other roofing companies. Eagle, CO – May 31, 2023 –

Central Roofing & Restoration, LLC Emphasizes the Significance of Eco-Friendly Shingles

Central Roofing & Restoration provides reliable commercial and residential roofing, gutter, screens, and window services. In a recent post, the company shared the importance of eco-friendly roofing shingles. Dallas, TX

1 2 3 … 22,900 Next Page

Malt Lymphoma Pipeline | Companies – MEI Pharma, Incyte, Genentech, BeiGene, Sound Biologics, ADC Therapeutics, Loxo Oncology, and Others

Loading, Please Wait!